The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American headache society position paper
Randolph W. Evans, Stewart J. Tepper, Robert E. Shapiro, Christina Sun-Edelstein, Gretchen E. Tietjen
Research output: Contribution to journal › Review article › peer-review
114
Link opens in a new tab
Scopus
citations